MATTEELLI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 18.088
AS - Asia 8.721
EU - Europa 5.355
SA - Sud America 2.146
AF - Africa 308
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 8
Totale 34.676
Nazione #
US - Stati Uniti d'America 17.818
SG - Singapore 3.155
CN - Cina 2.480
BR - Brasile 1.801
UA - Ucraina 1.446
HK - Hong Kong 1.069
IT - Italia 830
DE - Germania 770
VN - Vietnam 663
GB - Regno Unito 455
FR - Francia 402
TR - Turchia 389
FI - Finlandia 378
RU - Federazione Russa 333
IE - Irlanda 324
IN - India 299
ZA - Sudafrica 146
AR - Argentina 128
CA - Canada 122
BD - Bangladesh 116
MX - Messico 102
IQ - Iraq 98
PK - Pakistan 80
SE - Svezia 80
ID - Indonesia 70
EC - Ecuador 58
AT - Austria 56
ES - Italia 53
CO - Colombia 51
NL - Olanda 48
PL - Polonia 46
JP - Giappone 44
SA - Arabia Saudita 41
UZ - Uzbekistan 31
AU - Australia 30
BE - Belgio 28
KE - Kenya 26
MA - Marocco 25
PY - Paraguay 23
CL - Cile 21
MY - Malesia 21
VE - Venezuela 21
NZ - Nuova Zelanda 20
AE - Emirati Arabi Uniti 18
PE - Perù 16
RO - Romania 16
UY - Uruguay 15
CZ - Repubblica Ceca 14
EG - Egitto 14
IR - Iran 13
TN - Tunisia 13
DZ - Algeria 12
JO - Giordania 12
KZ - Kazakistan 12
LT - Lituania 12
OM - Oman 12
ET - Etiopia 11
IL - Israele 11
NP - Nepal 11
AZ - Azerbaigian 10
BG - Bulgaria 10
PH - Filippine 10
AL - Albania 9
GH - Ghana 9
JM - Giamaica 9
NG - Nigeria 9
LB - Libano 8
TW - Taiwan 8
DO - Repubblica Dominicana 7
EU - Europa 7
MU - Mauritius 7
RS - Serbia 7
TZ - Tanzania 7
AM - Armenia 6
GY - Guiana 6
CR - Costa Rica 5
HN - Honduras 5
HU - Ungheria 5
PS - Palestinian Territory 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
UG - Uganda 5
BO - Bolivia 4
CH - Svizzera 4
CI - Costa d'Avorio 4
KH - Cambogia 4
NO - Norvegia 4
PA - Panama 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
KG - Kirghizistan 3
NI - Nicaragua 3
SN - Senegal 3
TJ - Tagikistan 3
ZW - Zimbabwe 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
Totale 34.633
Città #
Fairfield 2.323
Singapore 1.707
Woodbridge 1.582
Ashburn 1.545
Houston 1.215
Jacksonville 1.064
Hong Kong 1.052
Seattle 952
Wilmington 833
Cambridge 827
Chandler 760
Princeton 604
Ann Arbor 603
The Dalles 574
Beijing 514
San Jose 462
New York 435
Dublin 324
Nanjing 307
Istanbul 303
Lauterbourg 301
Los Angeles 289
Ho Chi Minh City 255
Helsinki 240
São Paulo 164
Des Moines 151
Brescia 140
Moscow 137
San Diego 135
Hanoi 132
Munich 123
Buffalo 122
Dearborn 117
Nanchang 112
Redondo Beach 109
Council Bluffs 98
Changsha 93
Chicago 93
Milan 90
Shenyang 83
Shanghai 81
Nuremberg 76
San Francisco 76
London 75
Dallas 74
Tianjin 69
Hebei 64
Jinan 62
Orem 62
Santa Clara 60
Rio de Janeiro 56
Jiaxing 54
Chennai 46
Johannesburg 46
Rome 46
Belo Horizonte 43
Frankfurt am Main 41
New Delhi 41
Tokyo 39
Warsaw 38
Atlanta 37
Kocaeli 35
Montreal 35
Baghdad 33
Stockholm 33
Manchester 32
Brasília 31
Mexico City 31
Turku 30
Brooklyn 29
Tashkent 29
Toronto 29
Brussels 28
Curitiba 28
Denver 27
Guangzhou 27
Hangzhou 27
Haiphong 26
Kunming 26
Cape Town 25
Da Nang 25
Ningbo 25
Amsterdam 24
Messina 24
Norwalk 24
Poplar 24
Verona 23
Vienna 23
Guayaquil 22
Lanzhou 21
Quito 21
Lahore 20
Phoenix 20
Riyadh 20
Salt Lake City 20
Zhengzhou 20
Boardman 19
Durban 19
Lancaster 19
Mumbai 19
Totale 23.149
Nome #
Treatment of TB 489
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in adolescents in Northern Italy: an observational school-based study. 313
WHO strategies for the programmatic management of drug-resistant tuberculosis 290
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 231
Treatment patterns and associated costs for genital warts in Italy 201
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons 200
Towards tuberculosis elimination: An action framework for low-incidence countries 196
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 195
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: Different methodology and settings, same results 193
Rediscovering high technology from the past: Thoracic surgery is back on track for multidrug-resistant tuberculosis 183
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 178
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study 177
Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis. 172
Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis 171
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. 170
Louse-borne relapsing fever in a refugee from Mali 170
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 169
Chlamydia trachomatis genotypes in school adolescents, Italy 168
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 164
Global tuberculosis prevention: Should we start from the beginning? 163
Tuberculosis: epidemiology and control 162
Advances in the treatment of malaria 160
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe 156
Imported malaria in northern italy: Epidemiology and clinical features observed over 18 years in the teaching hospital of Brescia 154
A Strange Manifestation of Malaria in a Native Nigerian Boy 151
The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis 150
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB 149
Tuberculosis elimination and the challenge of latent tuberculosis 149
Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015 149
STI epidemics in the Indian Ocean Region: can the phase be assessed? 147
Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy 146
Identification of the skin virome in a boy with widespread human papillomavirus-2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine 146
Building a European database to gather multi-country evidence on active and latent TB screening for migrants 146
Fatal disseminated toxoplasmosis during primary HIV infection. 145
Risk assessment of tuberculosis in immunocompromised patients: A TBNET study 145
New Antituberculosis Drugs: From Clinical Trial to Programmatic Use 145
New italian guidelines for malaria prophylaxis in travellers to endemic areas 143
Latent tuberculous infection: Ethical considerations in formulating public health policy 143
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials 143
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study 143
Respiratory syndrome and respiratory tract infections in foreign-born and national travelers hospitalized with fever in Italy 143
Latent Mycobacterium tuberculosis infection 142
A scoping review of cost-effectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries 142
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012 142
Extensively drug-resistant tuberculosis: Epidemiology and management 142
Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting 142
Viral Load and Risk of Tuberculosis in HIV Infection 141
Recent developments in the diagnosis and management of tuberculosis 141
Mycobacterium sherrisii pulmonary disease, Burkina Faso 141
Travel-associated sexually transmitted infections: an observational cross-sectional study of the GeoSentinel surveillance database 140
The Holy Grail of prevention of sexually transmitted infections in travellers 140
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease 140
VAGINAL COLONIZATION WITH CANDIDA SPP IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN: A COHORT STUDY 139
Differences in BCG vaccination and tuberculin skin-test positivity 139
App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis 139
Travel-associated sexually transmitted infections: An observational cross-sectional study of the GeoSentinel surveillance database 138
Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: Tropnet data from the denguetools research initiative 138
Breaking the barriers: Migrants and tuberculosis 138
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso 137
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB 136
Assessing the impact of defining a global priority research agenda to address HIV-associated tuberculosis 136
Baggage Malaria in Italy: Cryptic Malaria explained? 134
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis 134
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area 134
In reply. Promoting ethical and evidence-based policies for latent tuberculosis 133
Recommendations for the diagnosis of pediatric tuberculosis 133
Prevalence of anti-poliovirus type 1, 2 and 3 antibodies in unvaccinated Italian travelers 132
Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection 132
Compassionate and optimum use of new tuberculosis drugs 131
Disseminated Mycobacterium genavense infection after immunosuppressive therapy shows underlying new composite heterozygous mutations of β1 subunit of IL-12 receptor gene. 130
Advancing global programmatic management of latent tuberculosis infection for at risk populations 130
Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV 130
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy 130
Prevalence and incidence of syphilis among South American transgender sex workers in Northern Italy 130
An epidemiological survey of vulvovaginal candidiasis in Italy 129
Multidisciplinary approach to prostatitis 128
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report 128
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy 126
Exogenous reinfection of tuberculosis in a low-burden area 126
Antiretroviral Therapy in HIV Infected Children with Tuberculosis: A Systematic Review 126
Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: Focus on drug-drug interactions with rifamycins 126
The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: A systematic review 126
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis 126
Recrudescence of Plasmodium falciparum malaria in a primigravidae woman with anemia as the only sign of diseases: a case report 126
Recommendations Concerning the Therapeutic Approach to Immunocompromised Children with Tuberculosis 125
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network 125
Ripped from the headlines: How can we harness communications to control TB? 125
Immune Responses to SARS-CoV-2 Infection and Vaccine in a Big Italian COVID-19 Hospital: An 18-Month Follow-Up 125
Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients. 123
Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy 123
The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: The study protocol 123
Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients [9] 123
INDAGINE SU CONSUMI DI ALCOOL, COMPORTAMENTI SESSUALI E INFEZIONI SESSUALMENTE TRASMESSE NELLA POPOLAZIONE ADOLESCENTE DELLA PROVINCIA DI BRESCIA 122
Epidemiological features and case-management practices of imported malaria in northern Italy 122
Molecular analysis of tetracycline-resistant gonococci: rapid detection of resistant genotypes using a real-time PCR assay 122
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries 122
Completion of screening for latent tuberculosis infection among immigrants 122
gammadelta T lymphocytes in the peripheral blood of patients with tuberculosis with and without HIV co-infection. 121
Acute respiratory distress syndrome in Plasmodium vivax malaria in traveler returning from Venezuela. 121
Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex 120
Totale 15.045
Categoria #
all - tutte 183.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.196 0 0 0 0 0 0 0 0 0 597 337 262
2021/20222.126 110 423 59 110 13 129 133 181 101 244 178 445
2022/20232.179 346 47 24 211 175 578 1 222 358 18 91 108
2023/20242.088 124 64 110 144 80 387 74 89 575 26 43 372
2024/20255.033 40 22 54 551 691 480 372 153 501 467 1.115 587
2025/202610.025 1.071 1.577 897 1.765 987 612 1.466 425 593 632 0 0
Totale 35.165